{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T13:19:42Z","timestamp":1770470382225,"version":"3.49.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2021YFC2302405"],"award-info":[{"award-number":["2021YFC2302405"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.ejphar.2025.177366","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T21:47:14Z","timestamp":1739310434000},"page":"177366","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Interleukin-35 mRNA therapy for influenza virus-induced pneumonia in mice"],"prefix":"10.1016","volume":"993","author":[{"given":"Yanyan","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuqin","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiqi","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changxiao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinrong","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiayu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Dou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cuiyun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2025.177366_bib1","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMra1000449","article-title":"Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection","volume":"362","author":"Bautista","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2025.177366_bib2","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1750-2659.2012.00360.x","article-title":"The impact of bacterial and viral co\u2010infection in severe influenza","volume":"7","author":"Blyth","year":"2012","journal-title":"Influenza and Other Respiratory Viruses"},{"key":"10.1016\/j.ejphar.2025.177366_bib3","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cell.2013.06.013","article-title":"A systems analysis identifies a feedforward inflammatory circuit leading to lethal influenza infection","volume":"154","author":"Brandes","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2025.177366_bib4","doi-asserted-by":"crossref","DOI":"10.1186\/1465-9921-6-135","article-title":"Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells","volume":"6","author":"Chan","year":"2005","journal-title":"Respir. Res."},{"key":"10.1016\/j.ejphar.2025.177366_bib5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.cyto.2016.01.016","article-title":"Interleukin-35 is upregulated in response to influenza virus infection and secondary bacterial pneumonia","volume":"81","author":"Chen","year":"2016","journal-title":"Cytokine"},{"key":"10.1016\/j.ejphar.2025.177366_bib6","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.antiviral.2009.08.006","article-title":"Amantadine-resistant influenza A viruses isolated in South Korea from 2003 to 2009","volume":"84","author":"Choi","year":"2009","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejphar.2025.177366_bib7","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nature06306","article-title":"The inhibitory cytokine IL-35 contributes to regulatory T-cell function","volume":"450","author":"Collison","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2025.177366_bib8","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1128\/CVI.00636-12","article-title":"Targeting the \u201ccytokine storm\u201d for therapeutic benefit","volume":"20","author":"D'Elia","year":"2013","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.ejphar.2025.177366_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.855474","article-title":"Pancreatic cancer: nucleic acid drug discovery and targeted therapy","volume":"10","author":"Dai","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ejphar.2025.177366_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-00838-4","article-title":"IL-12p35 induces expansion of IL-10 and IL-35-expressing regulatory B cells and ameliorates autoimmune disease","volume":"8","author":"Dambuza","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2025.177366_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.974433","article-title":"How far are the new wave of mRNA drugs from us? mRNA product current perspective and future development","volume":"13","author":"Duan","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2025.177366_bib12","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S1473-3099(14)70821-7","article-title":"Antiviral combinations for severe influenza","volume":"14","author":"Dunning","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejphar.2025.177366_bib13","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine storm","volume":"383","author":"Fajgenbaum","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2025.177366_bib14","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00281-017-0636-y","article-title":"New fronts emerge in the influenza cytokine storm","volume":"39","author":"Guo","year":"2017","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.ejphar.2025.177366_bib15","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1183\/09031936.00186214","article-title":"Influenza virus-induced lung injury: pathogenesis and implications for treatment","volume":"45","author":"Herold","year":"2015","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ejphar.2025.177366_bib16","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1080\/14760584.2017.1355245","article-title":"Mechanism of action of mRNA-based vaccines","volume":"16","author":"Iavarone","year":"2017","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.ejphar.2025.177366_bib17","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nri3665","article-title":"Innate immunity to influenza virus infection","volume":"14","author":"Iwasaki","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejphar.2025.177366_bib18","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1086\/596051","article-title":"Treatment with protein synthesis inhibitors improves outcomes of secondary bacterial pneumonia after influenza","volume":"199","author":"Karlstr\u00f6m","year":"2009","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ejphar.2025.177366_bib19","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1172\/JCI125863","article-title":"Plasmacytoid dendritic cells protect against immune-mediated acute liver injury via IL-35","volume":"129","author":"Koda","year":"2019","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2025.177366_bib20","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/s43018-020-0095-6","article-title":"Multifunctional oncolytic nanoparticles deliver self-replicating IL-12 RNA to eliminate established tumors and prime systemic immunity","volume":"1","author":"Li","year":"2020","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.ejphar.2025.177366_bib21","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1086\/591708","article-title":"Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness","volume":"198","author":"Morens","year":"2008","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ejphar.2025.177366_bib22","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1002\/eji.200737810","article-title":"IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells","volume":"37","author":"Niedbala","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ejphar.2025.177366_bib23","doi-asserted-by":"crossref","first-page":"6174","DOI":"10.1158\/1078-0432.CCR-21-0987","article-title":"Spatial mapping and immunomodulatory role of the OX40\/ox40l pathway in human non-small cell lung cancer","volume":"27","author":"Porciuncula","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejphar.2025.177366_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24087350","article-title":"Potential of Interleukin (IL)-12 group as antivirals: severe viral disease prevention and management","volume":"24","author":"Rahman","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.177366_bib25","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1097\/CCM.0b013e3182416f23","article-title":"Critical illness from 2009 pandemic influenza A virus and bacterial coinfection in the United States","volume":"40","author":"Rice","year":"2012","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.ejphar.2025.177366_bib26","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3810\/pgm.2009.05.2014","article-title":"Original research: intravenous ribavirin\u2014review of the FDA's emergency investigational new drug database (1997\u20132008) and literature review","volume":"121","author":"Riner","year":"2015","journal-title":"PGM (Postgrad. Med.)"},{"key":"10.1016\/j.ejphar.2025.177366_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms10061193","article-title":"Advanced molecular and immunological diagnostic methods to detect SARS-CoV-2 infection","volume":"10","author":"Rotondo","year":"2022","journal-title":"Microorganisms"},{"key":"10.1016\/j.ejphar.2025.177366_bib28","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.antiviral.2013.03.014","article-title":"Influenza virus resistance to neuraminidase inhibitors","volume":"98","author":"Samson","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejphar.2025.177366_bib29","doi-asserted-by":"crossref","first-page":"166","DOI":"10.2353\/ajpath.2010.100115","article-title":"2009 pandemic influenza A (H1N1)","volume":"177","author":"Shieh","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejphar.2025.177366_bib30","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/nm.4356","article-title":"Elimination of large tumors in mice by mRNA-encoded bispecific antibodies","volume":"23","author":"Stadler","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2025.177366_bib31","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.autrev.2018.01.017","article-title":"Emerging role of IL-35 in inflammatory autoimmune diseases","volume":"17","author":"Su","year":"2018","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.ejphar.2025.177366_bib32","first-page":"3","volume":"vol. II","author":"Teijaro","year":"2014"},{"key":"10.1016\/j.ejphar.2025.177366_bib33","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1128\/MMBR.05015-11","article-title":"Into the eye of the cytokine storm","volume":"76","author":"Tisoncik","year":"2012","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.ejphar.2025.177366_bib34","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nm.3554","article-title":"Interleukin-35 induces regulatory B cells that suppress autoimmune disease","volume":"20","author":"Wang","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2025.177366_bib35","doi-asserted-by":"crossref","first-page":"16863","DOI":"10.1074\/jbc.M115.693101","article-title":"Gene expression and antiviral activity of interleukin-35 in response to influenza A virus infection","volume":"291","author":"Wang","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2025.177366_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2023.108130","article-title":"Development and applications of mRNA treatment based on lipid nanoparticles","volume":"65","author":"Wang","year":"2023","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.ejphar.2025.177366_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2020.107534","article-title":"The challenge and prospect of mRNA therapeutics landscape","volume":"40","author":"Weng","year":"2020","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.ejphar.2025.177366_bib38","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.1039\/D1CS00617G","article-title":"Emerging mRNA technologies: delivery strategies and biomedical applications","volume":"51","author":"Xiao","year":"2022","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ejphar.2025.177366_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113523","article-title":"Traditional Chinese medicines as effective agents against influenza virus-induced pneumonia","volume":"153","author":"Yang","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2025.177366_bib40","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ebiom.2018.06.009","article-title":"Interleukin-12p35 knock out aggravates doxorubicin-induced cardiac injury and dysfunction by aggravating the inflammatory response, oxidative stress, apoptosis and autophagy in mice","volume":"35","author":"Ye","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ejphar.2025.177366_bib41","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1093\/cvr\/cvy263","article-title":"Interleukin-12p35 knockout promotes macrophage differentiation, aggravates vascular dysfunction, and elevates blood pressure in angiotensin II-infused mice","volume":"115","author":"Ye","year":"2019","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2025.177366_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.659419","article-title":"Quantification of cytokine storms during virus infections","volume":"12","author":"Yuan","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2025.177366_bib43","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.4049\/jimmunol.1600446","article-title":"IL-35 decelerates the inflammatory process by regulating inflammatory cytokine secretion and M1\/M2 macrophage ratio in psoriasis","volume":"197","author":"Zhang","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2025.177366_bib44","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.cell.2020.07.024","article-title":"A thermostable mRNA vaccine against COVID-19","volume":"182","author":"Zhang","year":"2020","journal-title":"Cell"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925001190?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925001190?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T17:16:40Z","timestamp":1741367800000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299925001190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":44,"alternative-id":["S0014299925001190"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177366","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interleukin-35 mRNA therapy for influenza virus-induced pneumonia in mice","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177366","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"177366"}}